The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials

Justine N. Whitham, Nicola J. Spurrier, Michael G. Sawyer, Peter A. Baghurst, John E. Taplin, Jason M. White, Andrea L. Gordon

Research output: Contribution to journalArticle

Abstract

This study compared the neurological development of 4 month old infants exposed to buprenorphine or methadone during pregnancy to that of a control group of non-exposed infants. Participants were 30 buprenorphine-maintained women, 22 methadone-maintained women and 33 non opioid-dependent controls, and their infants. Women were enrolled during pregnancy as part of an open-label non-randomised flexible-dosing longitudinal study. Groups were matched for maternal age, parity, gravida, and tobacco and alcohol use. Infant neurological development was assessed by measuring latency of pattern reversal visual evoked potentials (VEP). One-way between groups analyses of variance (ANOVA) were conducted to test the statistical significance of differences between the mean latencies of the peak response to two different sized checkerboard patterns (48′ and 69′ of retinal arc). Infants prenatally exposed to methadone had significantly prolonged latencies, compared with infants in the control group and infants prenatally exposed to buprenorphine, in response to checks of 48′ and 69′. VEP latencies of infants prenatally exposed to buprenorphine did not differ significantly from controls for either check size. After adjustment for covariates, prenatal exposure to methadone remained a significant predictor of VEP response to checks of 48′, but not 69′. Maternal self-reported used of marijuana during pregnancy made a significant unique contribution to the variance in P1 latencies for both check sizes. Data from this controlled, non-randomised study suggest that buprenorphine may confer an advantage over methadone as a maintenance drug during pregnancy in terms of infant neural development at 4 months of age.

Original languageEnglish (US)
Pages (from-to)280-288
Number of pages9
JournalNeurotoxicology and Teratology
Volume32
Issue number2
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Buprenorphine
Visual Evoked Potentials
Methadone
Bioelectric potentials
Pregnancy
Child Development
Tobacco
Cannabis
Opioid Analgesics
Control Groups
Labels
Maternal Age
Tobacco Use
Alcohols
Parity
Reaction Time
Longitudinal Studies
Analysis of Variance
Research Design
Maintenance

Keywords

  • Buprenorphine
  • Infant development
  • Methadone
  • Pregnancy
  • Prenatal opioid exposure
  • VEP

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Cellular and Molecular Neuroscience
  • Toxicology

Cite this

Whitham, J. N., Spurrier, N. J., Sawyer, M. G., Baghurst, P. A., Taplin, J. E., White, J. M., & Gordon, A. L. (2010). The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicology and Teratology, 32(2), 280-288. https://doi.org/10.1016/j.ntt.2009.09.001

The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. / Whitham, Justine N.; Spurrier, Nicola J.; Sawyer, Michael G.; Baghurst, Peter A.; Taplin, John E.; White, Jason M.; Gordon, Andrea L.

In: Neurotoxicology and Teratology, Vol. 32, No. 2, 03.2010, p. 280-288.

Research output: Contribution to journalArticle

Whitham, JN, Spurrier, NJ, Sawyer, MG, Baghurst, PA, Taplin, JE, White, JM & Gordon, AL 2010, 'The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials', Neurotoxicology and Teratology, vol. 32, no. 2, pp. 280-288. https://doi.org/10.1016/j.ntt.2009.09.001
Whitham, Justine N. ; Spurrier, Nicola J. ; Sawyer, Michael G. ; Baghurst, Peter A. ; Taplin, John E. ; White, Jason M. ; Gordon, Andrea L. / The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. In: Neurotoxicology and Teratology. 2010 ; Vol. 32, No. 2. pp. 280-288.
@article{bdb08486769f4604add17df8f35e97fb,
title = "The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials",
abstract = "This study compared the neurological development of 4 month old infants exposed to buprenorphine or methadone during pregnancy to that of a control group of non-exposed infants. Participants were 30 buprenorphine-maintained women, 22 methadone-maintained women and 33 non opioid-dependent controls, and their infants. Women were enrolled during pregnancy as part of an open-label non-randomised flexible-dosing longitudinal study. Groups were matched for maternal age, parity, gravida, and tobacco and alcohol use. Infant neurological development was assessed by measuring latency of pattern reversal visual evoked potentials (VEP). One-way between groups analyses of variance (ANOVA) were conducted to test the statistical significance of differences between the mean latencies of the peak response to two different sized checkerboard patterns (48′ and 69′ of retinal arc). Infants prenatally exposed to methadone had significantly prolonged latencies, compared with infants in the control group and infants prenatally exposed to buprenorphine, in response to checks of 48′ and 69′. VEP latencies of infants prenatally exposed to buprenorphine did not differ significantly from controls for either check size. After adjustment for covariates, prenatal exposure to methadone remained a significant predictor of VEP response to checks of 48′, but not 69′. Maternal self-reported used of marijuana during pregnancy made a significant unique contribution to the variance in P1 latencies for both check sizes. Data from this controlled, non-randomised study suggest that buprenorphine may confer an advantage over methadone as a maintenance drug during pregnancy in terms of infant neural development at 4 months of age.",
keywords = "Buprenorphine, Infant development, Methadone, Pregnancy, Prenatal opioid exposure, VEP",
author = "Whitham, {Justine N.} and Spurrier, {Nicola J.} and Sawyer, {Michael G.} and Baghurst, {Peter A.} and Taplin, {John E.} and White, {Jason M.} and Gordon, {Andrea L.}",
year = "2010",
month = "3",
doi = "10.1016/j.ntt.2009.09.001",
language = "English (US)",
volume = "32",
pages = "280--288",
journal = "Neurotoxicology and Teratology",
issn = "0892-0362",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials

AU - Whitham, Justine N.

AU - Spurrier, Nicola J.

AU - Sawyer, Michael G.

AU - Baghurst, Peter A.

AU - Taplin, John E.

AU - White, Jason M.

AU - Gordon, Andrea L.

PY - 2010/3

Y1 - 2010/3

N2 - This study compared the neurological development of 4 month old infants exposed to buprenorphine or methadone during pregnancy to that of a control group of non-exposed infants. Participants were 30 buprenorphine-maintained women, 22 methadone-maintained women and 33 non opioid-dependent controls, and their infants. Women were enrolled during pregnancy as part of an open-label non-randomised flexible-dosing longitudinal study. Groups were matched for maternal age, parity, gravida, and tobacco and alcohol use. Infant neurological development was assessed by measuring latency of pattern reversal visual evoked potentials (VEP). One-way between groups analyses of variance (ANOVA) were conducted to test the statistical significance of differences between the mean latencies of the peak response to two different sized checkerboard patterns (48′ and 69′ of retinal arc). Infants prenatally exposed to methadone had significantly prolonged latencies, compared with infants in the control group and infants prenatally exposed to buprenorphine, in response to checks of 48′ and 69′. VEP latencies of infants prenatally exposed to buprenorphine did not differ significantly from controls for either check size. After adjustment for covariates, prenatal exposure to methadone remained a significant predictor of VEP response to checks of 48′, but not 69′. Maternal self-reported used of marijuana during pregnancy made a significant unique contribution to the variance in P1 latencies for both check sizes. Data from this controlled, non-randomised study suggest that buprenorphine may confer an advantage over methadone as a maintenance drug during pregnancy in terms of infant neural development at 4 months of age.

AB - This study compared the neurological development of 4 month old infants exposed to buprenorphine or methadone during pregnancy to that of a control group of non-exposed infants. Participants were 30 buprenorphine-maintained women, 22 methadone-maintained women and 33 non opioid-dependent controls, and their infants. Women were enrolled during pregnancy as part of an open-label non-randomised flexible-dosing longitudinal study. Groups were matched for maternal age, parity, gravida, and tobacco and alcohol use. Infant neurological development was assessed by measuring latency of pattern reversal visual evoked potentials (VEP). One-way between groups analyses of variance (ANOVA) were conducted to test the statistical significance of differences between the mean latencies of the peak response to two different sized checkerboard patterns (48′ and 69′ of retinal arc). Infants prenatally exposed to methadone had significantly prolonged latencies, compared with infants in the control group and infants prenatally exposed to buprenorphine, in response to checks of 48′ and 69′. VEP latencies of infants prenatally exposed to buprenorphine did not differ significantly from controls for either check size. After adjustment for covariates, prenatal exposure to methadone remained a significant predictor of VEP response to checks of 48′, but not 69′. Maternal self-reported used of marijuana during pregnancy made a significant unique contribution to the variance in P1 latencies for both check sizes. Data from this controlled, non-randomised study suggest that buprenorphine may confer an advantage over methadone as a maintenance drug during pregnancy in terms of infant neural development at 4 months of age.

KW - Buprenorphine

KW - Infant development

KW - Methadone

KW - Pregnancy

KW - Prenatal opioid exposure

KW - VEP

UR - http://www.scopus.com/inward/record.url?scp=77649273122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649273122&partnerID=8YFLogxK

U2 - 10.1016/j.ntt.2009.09.001

DO - 10.1016/j.ntt.2009.09.001

M3 - Article

C2 - 19751825

AN - SCOPUS:77649273122

VL - 32

SP - 280

EP - 288

JO - Neurotoxicology and Teratology

JF - Neurotoxicology and Teratology

SN - 0892-0362

IS - 2

ER -